Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.80224 | 63 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.81807 | 64 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.80341 | 64 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.78421 | 63 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.78945 | 64 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.83549 | 63 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.74912 | 31 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.77906 | 63 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.83798 | 64 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.80037 | 64 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.7925 | 63 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.79512 | 64 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.78858 | 63 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.79357 | 63 |